Country for PR: China
Contributor: PR Newswire Asia (China)
Thursday, July 14 2022 - 18:48
AsiaNet
Tianlong launched a campaign to care for SMA children
XI'AN China, July 14, 2022 /PRNewswire-AsiaNet/

Tianlong has launched a campaign together with the Spinal muscular atrophy 
(SMA) care center in China (a non-profit organization for SMA), and The Second 
Affiliated Hospital of Xi'an Jiaotong University to care for children with SMA 
in May 2022.

Spinal muscular atrophy (SMA) is an inherited disease that affects nerves and 
muscles, causing muscles to become increasingly weak. It mostly affects infants 
and children but can also develop in adults, ranking as the first fatal genetic 
disease of infants.

Tianlong always bears social responsibility and strives for making more people 
know about the disease and helping with early detection. We want to make the 
world of SMA children full of love with deeds. During the campaign, we invited 
many families in Xi'an, China to join us to accompany SMA children one day. We 
have also invited a professor to give a lecture on SMA treatment and help 
answer concerns from parents.

A Day with SMA Children (PRNewsfoto/Xi'an TianLong Science and Technology Co., 
Ltd)

As a leading molecular diagnosis products manufacturer in China, Tianlong has 
PCR reagents covering 200 kinds of disease detection, including SMA detection. 
Based on the PCR melting curve method, Tianlong's Human Survival Motor Neuron 1 
(SMN1) Gene Detection Kit is suitable for the auxiliary diagnosis of SMN1 
patients and screening of SMN1 gene carriers. Besides PCR reagents, Tianlong 
can provide an integrated PCR lab solution from the nucleic acid extractor, and 
PCR systems to compatible reagents. We have helped over 80 countries in 
building up healthcare systems in the COVID-19 phase. Our Nucleic acid 
extractors and PCR machines have been a star in the war against COVID-19.

Every child is a gift to parents. They need to be nurtured with full love. 
Early detection can help with early diagnosis and treatment. We hope more 
people know about the rare disease and more SMA children and their families can 
be seen. We will bring technology to life and provide more solutions to better 
care for people globally.

Explore Tianlong : https://www.tlgenetech.cn/

Follow us on:

LinkedIn: https://www.linkedin.com/company/tianlongbiotech

Facebook:https://www.facebook.com/TianlongBiotech/

Twitter:https://twitter.com/TianlongBiotech

Contact us:

inquiry@medtl.com

SOURCE: Xi'an TianLong Science and Technology Co., Ltd

Image Attachments Links:

   Link: https://iop.asianetnews.net/view-attachment?attach-id=425362

Attachments
image-1 (1).jpg
Translations

Japanese